⌘K

Login Start Free

Home/Filings/4/0000899243-22-006546

4//SEC Filing

Palasis Maria 4

Accession 0000899243-22-006546

CIK 0001327273other

View on SEC.gov Company Profile

Filed

Feb 14, 7:00 PM ET

Accepted

Feb 15, 9:31 PM ET

Size

10.0 KB

Accession

0000899243-22-006546

Insider Transaction Report

Form 4

Period: 2022-02-12

Lyra Therapeutics, Inc.LYRA

DirectorPresident & CEO

Transactions

Award
Stock Option
2022-02-12+127,400→ 127,400 total
Exercise: $4.78Exp: 2032-02-11→ Common Stock (127,400 underlying)

Footnotes (1)

[F1]This option vests and becomes exercisable in 48 equal monthly installments occurring on the completion of each successive month of the Reporting Person's service to the Issuer following February 12, 2022.

Documents

2 files

Issuer

Lyra Therapeutics, Inc.

CIK 0001327273

Entity typeother

Related Parties

1

filerCIK 0001810701

Filing Metadata

Form type: 4
Filed: Feb 14, 7:00 PM ET
Accepted: Feb 15, 9:31 PM ET
Size: 10.0 KB

View on SEC.gov